Fundraising FoxLariotx
1 known investors
Find your way into Lariotx
Sign up to see every warm intro you have to Lariotx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lariotx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lario Therapeutics develops first-in-class precision medicines aimed at disease-modifying treatments for severe neurological disorders, including developmental and epileptic encephalopathies and Parkinson's disease. Its pipeline is built on genetically validated targets, focusing on early childhood syndromes and adult neurodegenerative conditions.
Investors · 1
Related companies · 4
ElicioElicio Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Applied TherapeuticsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.
Latigo BioLatigo Biotherapeutics is a clinical-stage biopharmaceutical company developing non-opioid pain medicines designed to stop pain transmission without addiction risk. The company aims to build a broad pipeline of pain therapeutics by leveraging its team's expertise in pain biology and clinical development.
Companies working in the same space as Lariotx.
Frequently asked questions
- What does Lariotx do?
- Lario Therapeutics develops first-in-class precision medicines aimed at disease-modifying treatments for severe neurological disorders, including developmental and epileptic encephalopathies and Parkinson's disease. Its pipeline is built on genetically validated targets, focusing on early childhood syndromes and adult neurodegenerative conditions.
- Who are Lariotx's investors?
- Lariotx's investors include Epidarex Capital.